FDA Recalls 90,000 Children's Ibuprofen Bottles Nationwide After Consumers Report Black Particles, Gel Mass

The US Food and Drug Administration (FDA) has recalled 89,592 bottles of children's ibuprofen sold nationwide after consumers reported finding black particles and a gel-like mass inside the liquid medication, raising alarm among parents who rely on the drug for their children's fevers and pain relief.

The voluntary recall was initiated on 2 March by Strides Pharma Inc., an India-headquartered pharmaceutical manufacturer with US operations in Bridgewater, New Jersey. But the FDA didn't formally classify the recall until 16 March, a two-week gap that left parents without a clear picture of the risk level during a critical window.

The agency has now designated it a Class II recall, meaning exposure to the product could cause temporary or medically reversible health problems. The probability of serious harm is considered remote.

What Parents Need to Check Right Now

The recall affects Children's Ibuprofen Oral Suspension, USP, 100 mg per 5 mL, packaged in 4-fluid-ounce (120 mL) bottles. Parents and caregivers should check the lot number printed on the bottle or packaging.

The two affected lots are 7261973A and 7261974A, both with an expiry date of 31 January 2027. The product's National Drug Code (NDC) is 51672-5321-8, and the FDA recall number is D-0390-2026.

The FDA said it has not received reports of serious adverse health effects connected to the recall. Anyone who has given a child the affected medication and noticed unusual symptoms should contact a healthcare provider immediately. Consumers can also report problems directly to the FDA through its MedWatch safety reporting system.

Made in India, Sold Across America

The recalled ibuprofen was manufactured in India by Strides Pharma for Taro Pharmaceuticals USA Inc., based in Hawthorne, New York. Taro became a wholly owned subsidiary of Sun Pharmaceutical Industries in June 2024, following a $348 million (£260 million) merger.

The supply chain adds a layer of complexity to the recall. Strides Pharma produced the medication at facilities in India, Taro distributed it under its US label, and it reached retailers across the country. However, neither company has publicly explained what the 'foreign substance' actually is or how it ended up in bottles meant for children.

As of 20 March, neither Strides Pharma nor Taro had issued a public statement addressing the nature of the contamination.

The Unanswered Question About Contamination

The FDA's enforcement report describes consumer complaints of 'a gel-like mass and black particles' in the product, but doesn't specify what the material is. The agency has not disclosed whether the contamination stems from a manufacturing defect, a raw material issue, or a packaging failure.

It is also unclear how many consumer complaints triggered the recall or whether photos of the contaminated product exist. The FDA's notice offered no images, and the total number of complaints hasn't been made public.

Ibuprofen is one of the most commonly administered over-the-counter medications for children. It's given for fevers, teething pain, headaches, and minor injuries. That nearly 90,000 bottles of a children's drug were distributed with an unidentified foreign substance, and no public explanation is the detail that separates this recall from routine FDA actions.

What To Do If You Have the Recalled Product

Health officials are urging anyone who has the affected bottles to stop using them immediately. Consumers can contact Taro Pharmaceuticals USA Inc. directly for questions about the recall or to request a refund.

The recall is ongoing, and the FDA has said it will continue monitoring the situation. But until Strides Pharma or Taro explains what the black particles and gel-like mass actually are, the most basic question parents are asking remains unanswered.